Insufficient scRNA-seq data for expression of ACCS at single-cell level.
Insufficient scRNA-seq data for expression of ACCS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 2771.38 | 653 / 653 | 99% | 11.76 | 601 / 605 |
| prostate | 100% | 2357.70 | 244 / 245 | 99% | 12.83 | 497 / 502 |
| pancreas | 100% | 1095.84 | 327 / 328 | 98% | 9.61 | 175 / 178 |
| kidney | 99% | 1843.57 | 88 / 89 | 98% | 11.18 | 880 / 901 |
| breast | 100% | 2374.95 | 457 / 459 | 95% | 7.22 | 1060 / 1118 |
| uterus | 100% | 2705.13 | 170 / 170 | 94% | 6.91 | 431 / 459 |
| ovary | 98% | 1882.00 | 177 / 180 | 95% | 7.44 | 409 / 430 |
| bladder | 100% | 1715.57 | 21 / 21 | 92% | 7.46 | 466 / 504 |
| adrenal gland | 100% | 3098.93 | 258 / 258 | 92% | 6.44 | 212 / 230 |
| skin | 95% | 1238.02 | 1719 / 1809 | 97% | 9.76 | 456 / 472 |
| lung | 100% | 1926.26 | 576 / 578 | 92% | 7.67 | 1061 / 1155 |
| esophagus | 98% | 1463.24 | 1416 / 1445 | 93% | 5.49 | 171 / 183 |
| liver | 99% | 1837.80 | 224 / 226 | 92% | 6.12 | 372 / 406 |
| intestine | 99% | 1668.99 | 960 / 966 | 90% | 5.07 | 473 / 527 |
| stomach | 100% | 1474.58 | 358 / 359 | 87% | 4.95 | 249 / 286 |
| brain | 46% | 218.48 | 1207 / 2642 | 62% | 3.69 | 439 / 705 |
| eye | 0% | 0 | 0 / 0 | 100% | 12.78 | 80 / 80 |
| spleen | 100% | 3133.89 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2132.28 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1758.86 | 1321 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 10.12 | 25 / 29 |
| heart | 83% | 676.37 | 712 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 3.82 | 33 / 45 |
| peripheral blood | 56% | 478.45 | 524 / 929 | 0% | 0 | 0 / 0 |
| muscle | 50% | 261.64 | 400 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0009058 | Biological process | biosynthetic process |
| GO_0006520 | Biological process | amino acid metabolic process |
| GO_0016847 | Molecular function | 1-aminocyclopropane-1-carboxylate synthase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0008483 | Molecular function | transaminase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0030170 | Molecular function | pyridoxal phosphate binding |
| Gene name | ACCS |
| Protein name | 1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1) 1-aminocyclopropane-1-carboxylate synthase-like protein (Non-functional) isoform 2 1-aminocyclopropane-1-carboxylate synthase-like protein (Non-functional) isoform 1 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) 1-aminocyclopropane-1-carboxylate synthase-like protein (Non-functional) isoform 4 |
| Synonyms | PHACS |
| Description | FUNCTION: Does not catalyze the synthesis of 1-aminocyclopropane-1-carboxylate but is capable of catalyzing the deamination of L-vinylglycine. . |
| Accessions | A0A0S2Z5S5 A0A0S2Z5Z8 A0A0S2Z622 E9PRT9 ENST00000263776.9 [Q96QU6-1] ENST00000524990.5 E9PS61 Q96QU6 ENST00000533404.1 |